This is GIANT news for anybody with cancer. Check this out! Finally using genetic editing to prime a patient's immune system to target individual specific cancer cells. This is super-targeted immunotherapy. This could illuminate any collateral damage from cancer treatment.
https://penntoday.upenn.edu/news/positive-results-first-us-trial-crispr-edited-immune-cells
No comments:
Post a Comment
Please be constructive in your comments.